Strutton DR - Search Results

1

Cost-effectiveness of pneumococcal conjugate vaccine: an update after 7 years of use in the United States.

Ray GT, Pelton SI, Klugman KP, Strutton DR, Moore MR. Ray GT, et al. Among authors: strutton dr. Vaccine. 2009 Nov 5;27(47):6483-94. doi: 10.1016/j.vaccine.2009.08.045. Epub 2009 Aug 29. Vaccine. 2009. PMID: 19720366

2

Modeling the decline in pneumococcal acute otitis media following the introduction of pneumococcal conjugate vaccines in the US.

Shea KM, Weycker D, Stevenson AE, Strutton DR, Pelton SI. Shea KM, et al. Among authors: strutton dr. Vaccine. 2011 Oct 19;29(45):8042-8. doi: 10.1016/j.vaccine.2011.08.057. Epub 2011 Aug 24. Vaccine. 2011. PMID: 21871518

3

7-Valent pneumococcal conjugate vaccine and lower respiratory tract infections: effectiveness of a 2-dose versus 3-dose primary series.

Pelton SI, Weycker D, Klein JO, Strutton D, Ciuryla V, Oster G. Pelton SI, et al. Vaccine. 2010 Feb 10;28(6):1575-82. doi: 10.1016/j.vaccine.2009.11.053. Epub 2009 Dec 8. Vaccine. 2010. PMID: 20003928

4

Public health and economic impact of the 13-valent pneumococcal conjugate vaccine (PCV13) in the United States.

Rubin JL, McGarry LJ, Strutton DR, Klugman KP, Pelton SI, Gilmore KE, Weinstein MC. Rubin JL, et al. Among authors: strutton dr. Vaccine. 2010 Nov 10;28(48):7634-43. doi: 10.1016/j.vaccine.2010.09.049. Epub 2010 Sep 28. Vaccine. 2010. PMID: 20883739

5

Public health and economic impact of vaccination with 7-valent pneumococcal vaccine (PCV7) in the context of the annual influenza epidemic and a severe influenza pandemic.

Rubin JL, McGarry LJ, Klugman KP, Strutton DR, Gilmore KE, Weinstein MC. Rubin JL, et al. Among authors: strutton dr. BMC Infect Dis. 2010 Jan 21;10:14. doi: 10.1186/1471-2334-10-14. BMC Infect Dis. 2010. PMID: 20092638 Free PMC article.

6

Modeling the impact of the 13-valent pneumococcal conjugate vaccine serotype catch-up program using United States claims data.

Strutton DR, Farkouh RA, Rubin JL, McGarry LJ, Loiacono PM, Klugman KP, Pelton SI, Gilmore KE, Weinstein MC. Strutton DR, et al. BMC Infect Dis. 2012 Aug 3;12:175. doi: 10.1186/1471-2334-12-175. BMC Infect Dis. 2012. PMID: 22863074 Free PMC article.

7

Impact of 13-valent pneumococcal conjugate vaccine (PCV13) in a pandemic similar to the 2009 H1N1 in the United States.

McGarry LJ, Gilmore KE, Rubin JL, Klugman KP, Strutton DR, Weinstein MC. McGarry LJ, et al. Among authors: strutton dr. BMC Infect Dis. 2013 May 21;13:229. doi: 10.1186/1471-2334-13-229. BMC Infect Dis. 2013. PMID: 23687999 Free PMC article.

8

Risk of pneumococcal disease in children with chronic medical conditions in the era of pneumococcal conjugate vaccine.

Pelton SI, Weycker D, Farkouh RA, Strutton DR, Shea KM, Edelsberg J. Pelton SI, et al. Among authors: strutton dr. Clin Infect Dis. 2014 Sep 1;59(5):615-23. doi: 10.1093/cid/ciu348. Epub 2014 May 13. Clin Infect Dis. 2014. PMID: 24825867

9

Rates and costs of invasive pneumococcal disease and pneumonia in persons with underlying medical conditions.

Weycker D, Farkouh RA, Strutton DR, Edelsberg J, Shea KM, Pelton SI. Weycker D, et al. Among authors: strutton dr. BMC Health Serv Res. 2016 May 13;16:182. doi: 10.1186/s12913-016-1432-4. BMC Health Serv Res. 2016. PMID: 27177430 Free PMC article.

10

Rates of pneumonia among children and adults with chronic medical conditions in Germany.

Pelton SI, Shea KM, Farkouh RA, Strutton DR, Braun S, Jacob C, Klok R, Gruen ES, Weycker D. Pelton SI, et al. Among authors: strutton dr. BMC Infect Dis. 2015 Oct 30;15:470. doi: 10.1186/s12879-015-1162-y. BMC Infect Dis. 2015. PMID: 26515134 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters